Research Topics
Subscribe to Research Topics
View Sample

FREE Email Newsletter

Daily news and top headlines for drug research professionals

Researchers Closer to Being Able to Change Blood Types

May 4, 2015 8:48 am | by University of British Columbia | News | Comments

What do you do when a patient needs a blood transfusion but you don’t have their blood type in the blood bank? It’s a problem that scientists have been trying to solve for years but haven’t been able to find an economic solution until now. Read more...

Progress Towards a New Asthma Treatment

May 4, 2015 8:42 am | by University of Queensland | News | Comments

Researchers are developing a new asthma treatment that targets the underlying cause of asthma, rather than just the symptoms. Read more...

Pakistani National Sold Drugs for Incurable Conditions, FDA Charges

May 1, 2015 4:28 pm | by Seth Augenstein, Digital Reporter | News | Comments

A Pakistani national has been indicted on fraud and other charges, according to federal authorities, after he allegedly sold bogus drugs to cure serious diseases — some of which are incurable. Read more...


Majority of Older Adults Willing to be Screened by Phone for Dementia: Study

May 1, 2015 12:15 pm | News | Comments

Nearly two-thirds of older adults were willing to undergo telephone screening for dementia, according to a new study from the Indiana University Center for Aging Research and the Regenstrief Institute. Willingness to be screened by phone did not differ by sex, age or race. Read more...

Apple's ResearchKit - The Real Impact on Clinical Trials

May 1, 2015 11:57 am | by Merrilyn Datta, Ph.D., President and General Manager, Definiens | Articles | Comments

Apple recently released news about its new ResearchKit, a medical platform that intends to turn the iPhone and HealthKit into diagnostic tools. The technology, which enables researchers to create apps that gather new types of health data from users who opt-in, has gotten quite a bit of attention throughout the healthcare and technology communities. Read more...

Braeburn Expands Pipeline to Include Two Schizophrenia Treatments

May 1, 2015 11:47 am | News | Comments

Braeburn Pharmaceuticals announced today that it has expanded its current therapeutic focus beyond addiction and pain to include schizophrenia and other serious psychiatric disorders. Read more..

Bayer's Contraception Safe, Effective: 5-Year Follow-Up Study

May 1, 2015 11:42 am | News | Comments

Bayer HealthCare announced today that a study published online this week in The Journal of Minimally Invasive Gynecology reinforces findings from previous clinical studies that support the effectiveness and safety of the Essure inserts and procedure for hysteroscopic sterilization, or permanent birth control. Read more...

AIT's Cystic Fibrosis Treatment Granted European Orphan Drug Designation

May 1, 2015 9:20 am | News | Comments

Advanced Inhalation Therapies Ltd (AIT), a leading anti-microbial therapeutic company, announced that the European Commission, acting on the recommendation from the Committee for Orphan Medicinal Products of the European Medicines Agency, granted orphan medicinal product designation to AIT-CF, the Company's proprietary high dose formulation of nitric oxide (NO), for the treatment of cystic fibrosis. Read more...


Is the World Failing in Fight Against Antibiotic Resistance?

May 1, 2015 9:09 am | by Bevin Fletcher, Associate Editor | News | Comments

Antimicrobial resistance is a growing global concern, one that the World Health Organization (WHO) is asking countries to ramp up efforts to prepare for. While many countries have strategies to address the issue, there are still a large number that do not have clear plans to curb misuse and reduce the spread of antimicrobial resistance, according to a new WHO report. Read more...

Genocea's GEN-003 in Prime Position to Lead GH Vaccine Space

April 30, 2015 4:50 pm | by Daian Cheng, Ph.D., GlobalData Infectious Disease Analyst | News | Comments

Genocea Biosciences’ investigational genital herpes (GH) vaccine, GEN-003, is better positioned to compete in the future GH treatment space, despite being slightly behind Agenus’ HerpV in clinical development, according to GlobalData. Read more..

Pressure Grows to End Blanket Bans on Gay Men Blood Donors

April 30, 2015 4:29 pm | by Associated Press | News | Comments

The European Union's top court on Wednesday joined a growing chorus of voices questioning whether it still makes sense to forever bar all gay men from donating blood. Read more...

Researchers Discover How Aspirin Fights Cancer

April 30, 2015 1:57 pm | by University of Minnesota | News | Comments

Taking aspirin reduces a person’s risk of colorectal cancer, but the molecular mechanisms involved have remained unknown until a recent discovery by The Hormel Institute, affiliated with the University of Minnesota. Read more...

The Prospect of Drugs to Treat Gluten Sensitivity

April 30, 2015 1:31 pm | by Stephanie Guzowski, Editor | News | Comments

Pharmaceutical companies are working to develop treatments as a first line of defense against gluten-sensitive symptoms — including abdominal pain, bloating, diarrhea, headaches and fatigue. Read more...


Prostate Cancer Combination Treatment Could Beat Disease at Its Own Game: Early Study

April 30, 2015 10:23 am | by Seth Augenstein, Digital Reporter | News | Comments

Through chemoimmunotherapy, a chemical one-two punch, a team of doctors said they are now having new success in mouse models. Read more...

Strong Link Found Between Dementia, Common Anticholinergic Drugs

April 30, 2015 9:41 am | by Cynthia Fox, Science Editor | Articles | Comments

There is a strong and possibly irreversible link between Alzheimer’s disease and many commonly used medications for insomnia, allergies, and depression, according to a large recent JAMA Internal Medicine study. Read more...

Gene Variants Show Potential in Predicting Rheumatoid Arthritis Outcomes

April 29, 2015 4:29 pm | by University of Manchester | News | Comments

New cohort studies have shown that certain genetic variants are associated with higher or lower risks of increased disease severity. Read more...

Biomarkers Could Predict Response to Antipsychotic Treatment

April 29, 2015 4:22 pm | by King's College London | News | Comments

Only half of patients with psychosis respond to current medications and there is still a lack of knowledge surrounding the factors causing this lack of response. Read more...

Valeant Raises Outlook after Completing Purchase of Salix

April 29, 2015 4:18 pm | by The Associated Press | News | Comments

Valeant's biggest businesses include dermatology, eye health, and neurology. Read more...

Flu Kills Millions of Birds, May Spread to Humans

April 29, 2015 1:41 pm | by Seth Augenstein, Digital Reporter | News | Comments

A strain of avian flu that has spread to chickens and turkeys in the Midwest and caused the death of millions of birds could make the jump to humans in time for next flu season, according to the U.S. Department of Agriculture and the Centers for Disease Control and Prevention. Read more..

Your Brain on Drugs: Functional Differences in Brain Communication in Cocaine Users

April 29, 2015 12:22 pm | by University of Texas Medical Branch | News | Comments

The brain function of people addicted to cocaine is different from that of people who are not addicted and often linked to highly impulsive behavior, according to a new scientific study. Read more...

Breaking Ground on Biologics

April 29, 2015 11:01 am | by Ryan Bushey, Associate Editor | Articles | Comments

One of the final sessions for the 2015 Experimental Biology Conference in Boston, Massachusetts was on biologics. Over the course of two and a half hours, a panel of scientists and experts discussed their research and where they see opportunity in this field. Read more...

3 Ways Technology is Changing the Face of Drug Discovery & Development

April 29, 2015 9:04 am | by Merrilyn Datta, PhD, President and General Manager, Definiens | Articles | Comments

While personalized medicine has been a goal for some time, there have been several obstacles. Although there has been an explosion in genomic data, the corresponding clinical utility for this data has been slow to be validated. Read more...

World Malaria Day Brings Scourge into Spotlight

April 29, 2015 8:35 am | by Seth Augenstein, Digital Reporter | News | Comments

Malaria kills more than half a million people each year worldwide – and that’s after dramatic declines over the last decade. Read more...

Action Against Antibiotic Resistance Begins with Community

April 28, 2015 4:43 pm | by Wellcome Sanger Institute | News | Comments

To combat antibiotic resistance, scientists need to understand the evolution of bacteria and examine this alongside the characteristics of the populations they infect. Read more...

Novartis Announces Phase 3 Study of CLL Drug Met Primary Endpoint

April 28, 2015 4:34 pm | News | Comments

The safety profile observed in this trial is consistent with other trials of Arzerra and no new safety signals were observed. Read more....

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.